S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Diffusion Pharmaceuticals (DFFN) SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.

Recent Diffusion Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/28/2024
3:15 PM
Diffusion Pharmaceuticals (Filer)
CervoMed Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
8:23 AM
AI EIPP Holdings LLC (Filed by)
Diffusion Pharmaceuticals (Subject)
CervoMed Inc. (Subject)
Form SC 13G/A
02/09/2024
4:02 PM
BOGER JOSHUA S (Filed by)
Diffusion Pharmaceuticals (Subject)
CervoMed Inc. (Subject)
Form SC 13D
02/09/2024
3:31 PM
BOGER JOSHUA S (Reporting)
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/02/2024
3:17 PM
Diffusion Pharmaceuticals (Filer)
CervoMed Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
5:43 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Cobuzzi Robert Joseph Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
5:44 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Gregoire Sylvie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
5:45 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
ELDER WILLIAM ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
5:46 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
TANNER JOHN WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
5:46 PM
Blackburn Kelly (Reporting)
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
5:47 PM
ALAM JOHN J (Reporting)
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:05 PM
Diffusion Pharmaceuticals (Filer)
CervoMed Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
5:30 AM
Diffusion Pharmaceuticals (Filer)
CervoMed Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2023
6:41 PM
ALAM JOHN J (Reporting)
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
6:41 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Gregoire Sylvie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2023
4:18 PM
Diffusion Pharmaceuticals (Filer)
CervoMed Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
3:21 PM
Diffusion Pharmaceuticals (Filer)
CervoMed Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/29/2023
3:21 PM
Diffusion Pharmaceuticals (Filer)
CervoMed Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/15/2023
5:54 PM
ALAM JOHN J (Reporting)
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:55 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
TANNER JOHN WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
6:02 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Cobuzzi Robert Joseph Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:49 PM
Blackburn Kelly (Reporting)
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:50 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
DAVIDSON JILL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:51 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
ELDER WILLIAM ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:51 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Gregoire Sylvie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:52 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Hollingsworth Jane H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:52 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Poulton Jeffrey V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:53 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Sabbagh Marwan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:53 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
ZAVRL FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
3:31 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Hollingsworth Jane H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
6:34 PM
Diffusion Pharmaceuticals (Subject)
CervoMed Inc. (Subject)
ZAVRL FRANK (Filed by)
Form SC 13D
08/25/2023
5:26 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
ZAVRL FRANK (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/24/2023
8:30 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Sabbagh Marwan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2023
8:46 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
TANNER JOHN WILLIAM (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2023
8:48 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Poulton Jeffrey V. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2023
8:50 PM
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Gregoire Sylvie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2023
8:52 PM
ALAM JOHN J (Reporting)
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2023
8:52 PM
Blackburn Kelly (Reporting)
Diffusion Pharmaceuticals (Issuer)
CervoMed Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/11/2023
7:16 PM
DAVIDSON JILL (Reporting)
Diffusion Pharmaceuticals (Issuer)
Diffusion Pharmaceuticals Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/03/2023
3:15 PM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
3:15 PM
Diffusion Pharmaceuticals (Subject)
Diffusion Pharmaceuticals Inc. (Subject)
Form 425
08/03/2023
7:32 AM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
7:33 AM
Diffusion Pharmaceuticals (Subject)
Diffusion Pharmaceuticals Inc. (Subject)
Form 425
07/13/2023
11:15 PM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form EFFECT
07/13/2023
3:32 PM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form 424B3
07/11/2023
6:38 PM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form S-4/A
07/05/2023
4:30 PM
Diffusion Pharmaceuticals (Issuer)
Diffusion Pharmaceuticals Inc. (Issuer)
LANCHONEY DIANA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
8:46 PM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form S-4/A
06/21/2023
3:05 PM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
7:22 AM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2023
4:04 PM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
4:04 PM
Diffusion Pharmaceuticals (Subject)
Diffusion Pharmaceuticals Inc. (Subject)
Form 425
05/10/2023
8:56 PM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form S-4
Registration statement under Securities Act of 1933  
04/03/2023
4:49 PM
Diffusion Pharmaceuticals (Issuer)
Diffusion Pharmaceuticals Inc. (Issuer)
LANCHONEY DIANA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2023
3:55 PM
Diffusion Pharmaceuticals (Subject)
Diffusion Pharmaceuticals Inc. (Subject)
Form 425
03/30/2023
7:50 AM
Diffusion Pharmaceuticals (Filer)
Diffusion Pharmaceuticals Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2023
7:51 AM
Diffusion Pharmaceuticals (Subject)
Diffusion Pharmaceuticals Inc. (Subject)
Form 425
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:DFFN) was last updated on 3/3/2024 by MarketBeat.com Staff